ANI PHARMACEUTICALS INC (ANIP) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$883.4M

Net Income/Loss (FY2025)

$78.3M

Total Assets (FY2025)

$1.4B

Total Equity (FY2025)

$540.7M

Cash Flows from Operating Activities (FY2025)

$185.2M

Source: ANI PHARMACEUTICALS INC 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.